Abstract
Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-Term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.
| Original language | English |
|---|---|
| Pages (from-to) | S30-S34 |
| Journal | International Journal of Gynecological Cancer |
| Volume | 24 |
| Issue number | 9 |
| DOIs | |
| State | Published - Nov 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- Hypercalcaemia
- Pulmonary type
- Radiation therapy
- Rare cancers
- Small cell carcinoma ovary
- Surgery
Fingerprint
Dive into the research topics of 'Gynecologic cancer interGroup (GCIG) consensus review for ovarian small cell cancers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver